Aurora Cannabis Receives EU GMP Certification for its Aurora River Facility

  • Achievement increases total production capacity available to serve international medical markets by 230%
  • Brings Aurora’s total number of EU GMP certified Canadian production facilities to 3
  • Pharmacies in Germany have been instructed to resume sales of Aurora’s suite of medical cannabis following temporary pause

NYSE | TSX : ACB

EDMONTON , Feb. 3, 2020 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today its Aurora River production facility, located in Bradford, Ontario , has received European Union Good Manufacturing Practice (“EU GMP”) certification. EU GMP certification is granted to companies whose production facilities demonstrate a high degree of quality and consistency in their manufacturing procedures and is a requirement for the export of medical cannabis products into most European markets.

Aurora Cannabis Inc. (CNW Group/Aurora Cannabis Inc.)

View photos

Aurora Cannabis Inc. (CNW Group/Aurora Cannabis Inc.)

In addition, Aurora is pleased to announce it has received all necessary approvals from local regulators in Germany for sales of its medical cannabis products, following a temporary sales suspension on certain products in December 2019 . Aurora will fulfill existing sales orders from inventory currently held in Germany , ensuring local patients will have immediate access to medicine from their preferred pharmacy.

Yahoo Finance

Read The Full Article: Aurora Cannabis Receives EU GMP Certification for its Aurora River Facility

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.